Hypoglycemia as a sign of paraneoplastic syndrome in a patient with pleural fibroma
Keywords:
hypoglycemia, insulin growth factor 2, non-islet cell tumors, paraneoplastic syndrome, therapyAbstract
Paraneoplastic syndrome has a wide range of symptoms and fasting hypoglycemia is one of its possible clinical manifestations. It is mostly caused by insulinomas and non-islet cell tumors (large mesenchymal tumors account for more than a half of all neoplasms associated with hypoglycemia). Clinical features may vary and typical laboratory features of paraneoplastic hypoglycemia includes low level of fasting glucose and C-peptide, low insulin growth factor 1 (IGF1) and elevated level of “big” insulin growth factor 2 (IGF2). The increased IGF2 : IGF1 ratio is considered to be pathognomic for this diagnosis. Although paraneoplastic hypoglycemia is mostly present in patients with the already diagnosed malignancy, it is necessary to consider this opportunity in patients having unclear and inexplicable hypoglycemia. The adequate treatment can significantly reduce the symptoms and improve the quality of life.
Downloads
Published
Issue
Section
License
OPEN ACCESS
All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.
The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).
Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.